Dividends per common share $ $ $ $ 0.375

Size: px

Start display at page:

Download "Dividends per common share $ $ $ $ 0.375"

Daniela Payne
5 years ago
Views:

1 CONSOLIDATED STATEMENTS OF OPERATIONS (Dollars in millions, except per share amounts) Three Months Ended Net sales $ $455.4 $ 1,455.1 $ 1,237.4 Manufacturing cost of sales Selling and technical services Research and process development Administrative and general Amortization of acquisition intangibles Asset impairment charge Earnings from operations Other expense, net Loss on early extinguishment of debt Equity in loss of associated companies Interest expense, net Earnings from continuing operations before income taxes Income tax provision Earnings from continuing operations Earnings from discontinued operations before loss on sale, net of tax Loss on sale of discontinued operations, net of tax (0.6) (15.5) (32.9) (15.5) (Loss)/Earnings from discontinued operations, net of tax (0.6) 24.2 (1.3) 77.9 Net earnings Less: Net earnings attributable to noncontrolling interests - (0.5) (0.4) (1.5) Net earnings attributable to Cytec Industries Inc. $ 43.8 $ 58.4 $ $ Comprehensive income $ 66.5 $ 89.7 $ 52.6 $ Less: Comprehensive income attributable to noncontrolling interest - (0.6) (0.2) (1.3) Comprehensive income attributable to Cytec Industries Inc. $ 66.5 $ 89.1 $ 52.4 $ Earnings/(loss) per share attributable to Cytec Industries Inc. Basic earnings per common share Continuing operations $ 1.23 $ 0.75 $ 2.85 $ 1.55 Discontinued operations (net of noncontrolling interest) (0.02) 0.51 (0.04) 1.66 Diluted earnings/(loss) per common share $ 1.21 $ 1.26 $ 2.81 $ 3.21 Continuing operations $ 1.20 $ 0.74 $ 2.79 $ 1.53 Discontinued operations (net of noncontrolling interest) (0.01) 0.50 (0.04) 1.63 $ 1.19 $ 1.24 $ 2.75 $ 3.16 Dividends per common share $ $ $ $ Shares used in calculating earnings per common share (in 000s) Basic 36,232 46,359 40,660 46,190 Diluted 36,948 47,153 41,427 46,916

2 CONSOLIDATED NET SALES AND EARNINGS FROM OPERATIONS BY BUSINESS SEGMENT (Dollars in millions) Three Months Ended Net Sales: Aerospace Materials Sales to external customers $ $ $ Intersegment sales Industrial Materials In Process Separation Additive Technologies Sales to external customers Intersegment sales Net sales from segments , ,238.0 Elimination of intersegment revenue (0.1) (0.2) (0.7) (0.6) Total consolidated net sales $ $ ,455.1 $ 1,237.4 Three months ended Nine months ended % of % of % % of 2013 Sales 2012 Sales 2013 Sale 2012 Sales Earnings from operations: Aerospace Materials $ % $ % $ % $ % Industrial Materials % % % % In Process Separation % % % % Additive Technologies % % % % Earnings from segments % % % % Corporate and Unallocated, net (1) (11.0) (28.3) (30.8) (98.5) Total earnings from operations $ % $ % $ % $ % (1) Corporate and Unallocated includes the following: Three months ended Nine months ended Net restructuring adjustments $ 4.5 $ 4.6 $ 5.1 $ 15.9 Asset write-off related to a facility in Nagpur, India Pension and OPEB mark-to-market (benefit) adjustment - - (1.9) 13.9 Umeco acquisition costs Cost to divest Umeco Distribution business Incremental accelerated depreciation related to sale of R&D facility in Stamford, CT Continuing costs previously allocated to Coating Resins T otal $ 5.3 $ 29.9 $ 19.6 $ 94.1 CYTEC INDUSTRIES INC. AND SUBSIDIARIES % CHANGE IN SALES ANALYSIS BY SEGMENT VERSUS PRIOR YEAR Three Months Ended 2013 Segment Volume Acquisition Price FX Volume Acquisition Price FX Aerospace Materials 2% 2% 3% 0% 3% 6% 3% 0% Industrial Materials -9% 9% 1% 0% NM NM NM NM In Process Separation -5% 0% -2% 0% -1% 0% 0% 0% Additive Technologies 0% 0% -1% 0% -1% 0% 0% 0% Total Cytec Continuing Operations -1% 2% 1% 0% 0% 16% 2% 0% NM - not meaningful since majority of the difference is due to acquisition 2013 % Variance Due To % Variance Due To

3 CONSOLIDATED BALANCE SHEET (Dollars in millions, except per share amounts) December 31, Assets Current assets Cash and cash equivalents $176.6 $179.3 Trade accounts receivable, less allowance for doubtful accounts of $5.1 and $4.7 as of 2013 and December 31, 2012, respectively Other accounts receivable Inventories Deferred income taxes Other current assets Assets held for sale Total current assets ,218.8 Investment in associated companies Plants, equipment and facilities, at cost 1, ,310.4 Less: accumulated depreciation (509.2) (475.1) Net plant investment 1, Acquisition intangibles, net of accumulated amortization of $54.3 and $43.9 as of 2013 and December 31, 2012, respectively Goodwill Deferred income taxes Other assets Assets held for sale - 1,061.8 Total assets $2,644.3 $3,924.2 Liabilities Current liabilities Accounts payable $205.8 $176.4 Short-term borrowings Current maturities of long-term debt Accrued expenses Income taxes payable Deferred income taxes Liabilities held for sale Total current liabilities Long-term debt Pension and other postretirement benefit liabilities Other noncurrent liabilities Deferred income taxes Liabilities held for sale Stockholders' equity Preferred stock, 20,000,000 shares authorized; none issued and outstanding - - Common stock, $.01 par value per share, 150,000,000 shares authorized; issued 49,711,909 at 9/30/13 and 49,618,861 shares at 12/31/ Additional paid-in capital Retained earnings 1, ,419.2 Accumulated other comprehensive income/(loss) Treasury stock, at cost, 14,278,697 shares in 2013 and 4,672,700 shares in 2012 (958.9) (243.3) Total Cytec Industries Inc. stockholders' equity 1, ,797.7 Noncontrolling interest Total equity 1, ,803.0 Total liabilities and stockholders' equity $2,644.3 $3,924.2

4 CONSOLIDATED STATEMENTS OF CASH FLOWS (dollars in millions) Cash flows (used in) provided by operating activities Net earnings $114.5 $149.6 Earnings from discontinued operations (1.3) 77.9 Earnings from continuing operations Adjustments to reconcile net income to net cash provided by operating activities of continuing operations: Depreciation Amortization Share-based compensation Deferred income taxes (14.8) (7.3) Asset impairment charges Loss on early extinguishment of debt Unrealized gain on derivative instruments Other Changes in operating assets and liabilities (excluding effects of acquisitions and divestitures): Trade accounts receivable 4.3 (18.1) Other receivables Inventories (17.0) (21.3) Other assets 9.3 (0.9) Accounts payable 18.4 (9.2) Accrued expenses (3.7) 16.2 Income taxes payable (49.4) 19.7 Other liabilities (95.6) (19.2) Net cash provided by operating activities of continuing operations Net cash (used in) provided by operating activities of discontinued operations (107.4) 82.1 Net cash (used in) provided by operating activities (18.0) Cash flows provided by (used in) investing activities: Additions to plants, equipment and facilities (217.5) (84.3) Acquisition of businesses, net of cash received - (445.4) Net cash used in investing activities of continuing operations (217.5) (529.7) Net cash provided by investing activities of discontinued operations 1, Net cash provided by (used in) investing activities (432.3) Cash flows provided by (used in) financing activities: Proceeds from long-term debt Payments on long-term debt (658.2) (202.4) Change in short-term borrowings Cash dividends (17.1) (20.2) Proceeds from the exercise of stock options Purchase of treasury stock (750.1) - Excess tax benefits from share-based payment arrangements Other - (1.1) Net cash (used in) provided by financing activities (763.4) 17.7 Effect of currency rate changes on cash and cash equivalents (5.8) 2.3 Decrease in cash and cash equivalents (2.7) (226.3) Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period $176.6 $189.5

5 Reconciliation of GAAP and Non GAAP Measures (Amounts in millions, except per share amounts) Management believes that net earnings and diluted earnings per share before special items, which are non-gaap measurements, are meaningful to investors because they provide a view of the Company with respect to ongoing operating results. Special items represent significant charges or credits that are important to an understanding of the Company's overall operating results in the periods presented. Such non-gaap measurements are not recognized in accordance with generally accepted accounting principles (GAAP) and should not be viewed as an alternative to GAAP measures of performance. Three Months Ended 2013 GAAP earnings from continuing operations $ 44.4 $ Net restructuring charges Cost to divest Umeco Distribution business Write-offs related to a manufacturing facility in Nagpur, India Environmental liability adjustments Revision to established tax liability on unrepatriated earnings of foreign subsidiaries resulting from intended sale of Coating Resins business Non-GAAP net earnings from continuing operations $ 49.4 $ 1.34 Three Months Ended 2012 GAAP earnings from continuing operations $ 34.7 $ Incremental accelerated depreciation related to sale of R&D facility in Stamford, CT Umeco acquisition costs Net restructuring charges Amortization of inventory step-up Exchange loss on intercompany loan related to Umeco acquisition Non-GAAP net earnings from continuing operations $ 46.5 $ GAAP earnings from continuing operations $ $ Net restructuring charges Write-offs related to a manufacturing facility in Nagpur, India Cost to divest Umeco Distribution business Loss related to exit of process materials joint venture in China Environmental liability adjustments Pension and OPEB MTM adjustments (1.2) (0.03) - Premiums paid on early tender for public debts Revision to established tax liability on unrepatriated earnings of foreign subsidiaries resulting from intended sale of Coating Resins business (0.7) (0.02) Non-GAAP net earnings from continuing operations $ $ GAAP earnings from continuing operations $ 71.7 $ Incremental accelerated depreciation related to sale of R&D facility in Stamford, CT Umeco acquisition costs Net restructuring charges Established tax liability on unrepatriated earnings of foreign subsidiaries resulting from intended sale of Coating Resins business Amortization of inventory step-up Exchange loss on intercompany loan related to Umeco acquisition Pension and OPEB MTM adjustments Non-GAAP net earnings from continuing operations $ $ 2.52

DANA HOLDING CORPORATION Quarterly Financial Information and Reconciliations of Non-GAAP Financial Measures

DANA HOLDING CORPORATION Quarterly Financial Information and Reconciliations of Non-GAAP Financial Measures Quarterly Financial Information and Reconciliations of Non-GAAP Financial Measures Non-GAAP Financial Measures Adjusted EBITDA is a non-gaap financial measure which we have defined as earnings from continuing